COLUMVI

Google image searchProduct monograph

Active ingredient

glofitamab, 2.5 MG/2.5 ML

DIN: 02536552

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE-USE VIAL 1MG/ML

Schedule: Prescription / Schedule D

Company: HOFFMANN-LA ROCHE LIMITED

Date: 05-JUL-2023

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
• L01FX — Other monoclonal antibodies and antibody drug conjugates (ATC, ATC/DDD)
• L01FX28 — GLOFITAMAB (ATC/DDD)

External Links for Columvi

Search on Google

• Columvi side effects
• Columvi dosage
• glofitamab side effects
• glofitamab dosage

Hoffmann-La Roche Limited

Go to Hoffmann-La Roche website to see drug product details. Sometimes you can find columvi photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.